Citalopram Hydrobromide, 59729-32-7 API Manufacturers&Suppliers in India

Citalopram Hydrobromide API Manufacturers and Suppliers in India: A Comprehensive Guide


Citalopram Hydrobromide (CAS number: 59729-32-7) is a widely used active pharmaceutical ingredient (API) primarily prescribed as an antidepressant. This pharmaceutical compound belongs to the class of selective serotonin reuptake inhibitors (SSRIs) and is commonly used to treat conditions such as depression, anxiety disorders, panic attacks, and obsessive-compulsive disorder (OCD). Citalopram works by increasing serotonin levels in the brain, which helps improve mood and alleviate symptoms associated with mental health disorders.


India is one of the world's leading manufacturers of pharmaceutical APIs, and Citalopram Hydrobromide is among the widely produced APIs within the country. The combination of high-quality manufacturing processes, advanced technologies, and competitive pricing has made India a prime destination for sourcing Citalopram Hydrobromide API. In this article, we will provide a comprehensive look at the importance of Citalopram Hydrobromide, its manufacturing process, and why India is a preferred hub for global sourcing of this critical API.

What is Citalopram Hydrobromide?


Citalopram Hydrobromide is the hydrobromide salt form of Citalopram, a medication that is used primarily as an antidepressant in the treatment of various mental health conditions. As a selective serotonin reuptake inhibitor (SSRI), it works by increasing the levels of serotonin, a neurotransmitter in the brain that regulates mood, in the synaptic clefts of neurons. This leads to an improvement in mood and a reduction in symptoms of anxiety and depression.

Chemical Structure and Properties


Citalopram Hydrobromide has the chemical formula C20H21FN2O·HBr and is typically produced as a white to off-white crystalline powder that is soluble in water. The hydrobromide form of Citalopram improves its solubility, making it easier for the body to absorb and exert its therapeutic effects.

The molecular weight of Citalopram Hydrobromide is 396.40 g/mol. The molecule is composed of a bicyclic structure containing a benzene ring and a piperazine ring with a fluorine atom and a secondary amine group.

Pharmacology and Mechanism of Action


Citalopram Hydrobromide is classified as a second-generation SSRI, and it is commonly prescribed for various mental health conditions, including:

  • Major Depressive Disorder (MDD): Citalopram helps alleviate symptoms such as sadness, lack of interest, fatigue, and sleep disturbances associated with depression.

  • Generalized Anxiety Disorder (GAD): It helps reduce excessive anxiety, tension, and worry.

  • Panic Disorder: Citalopram is used to prevent and manage panic attacks.

  • Obsessive-Compulsive Disorder (OCD): The medication helps reduce the obsessive thoughts and compulsive behaviors characteristic of OCD.


By selectively inhibiting the reuptake of serotonin in the brain, Citalopram increases the concentration of serotonin available to bind to receptors on nerve cells, improving communication between brain cells and leading to enhanced mood and reduced anxiety.

Manufacturing of Citalopram Hydrobromide API


The production of Citalopram Hydrobromide is a highly complex and regulated process that requires precision and adherence to stringent standards. India has established itself as one of the leading producers of Citalopram Hydrobromide, due to its advanced pharmaceutical manufacturing capabilities, adherence to Good Manufacturing Practices (GMP), and cost advantages.

The Manufacturing Process of Citalopram Hydrobromide



  1. Synthesis of the Base Compound (Citalopram): The first step in the production of Citalopram Hydrobromide involves the synthesis of the base compound Citalopram, a chiral intermediate compound that undergoes several chemical reactions. The base compound is synthesized using organic chemical reactions, including halogenation, alkylation, and condensation, which form the core structure of the molecule.

  2. Hydrobromide Salt Formation: Once the base compound is synthesized, it is reacted with hydrobromic acid to form Citalopram Hydrobromide, the salt form of the compound. The formation of the hydrobromide salt enhances the solubility and stability of Citalopram, making it more suitable for pharmaceutical applications.

  3. Purification: After the formation of the hydrobromide salt, the crude Citalopram Hydrobromide undergoes a series of purification processes. This may include recrystallization, solvent washing, and filtration to remove any impurities or by-products that may have been generated during the synthesis.

  4. Drying: The purified Citalopram Hydrobromide is then dried to remove any residual solvents or moisture, ensuring that the final API is in a stable, usable form. The drying process is critical to ensuring the quality and potency of the API.

  5. Quality Control and Testing: Citalopram Hydrobromide undergoes rigorous testing and quality control procedures to ensure it meets the required pharmacological standards. These tests include:

    • Identity Testing: To verify the chemical structure of the compound.

    • Purity Testing: To ensure the API is free from impurities and meets specified purity standards.

    • Content Assay: To determine the concentration of the active ingredient.

    • Residual Solvent Testing: To ensure there are no leftover solvents that could compromise the safety of the API.

    • Microbial Testing: To ensure the absence of harmful microorganisms.



  6. Packaging and Distribution: Once the API has passed all necessary quality control tests, it is packaged in suitable containers to protect it from moisture, light, and other environmental factors. The API is then ready for distribution to pharmaceutical manufacturers, wholesalers, and other stakeholders in the global market.


Why Choose India for Sourcing Citalopram Hydrobromide API?


India is one of the largest producers and suppliers of APIs in the world, and the pharmaceutical industry in India has made remarkable strides in API production. Several factors contribute to India's competitive advantage as a source for Citalopram Hydrobromide API.

1. Cost-Effective Production:


India offers a significant cost advantage when compared to other countries due to its low labor costs, efficient manufacturing practices, and economies of scale. This allows Indian manufacturers to produce high-quality Citalopram Hydrobromide API at a competitive price, which is attractive to pharmaceutical companies worldwide.

2. Regulatory Compliance:


Indian pharmaceutical manufacturers follow stringent regulatory standards such as Good Manufacturing Practices (GMP), which are set by organizations such as the World Health Organization (WHO), US Food and Drug Administration (FDA), and European Medicines Agency (EMA). This ensures that Citalopram Hydrobromide API produced in India is of the highest quality and complies with international standards.

3. Advanced Manufacturing Facilities:


India's pharmaceutical industry boasts modern and well-equipped manufacturing facilities, which are capable of producing complex APIs like Citalopram Hydrobromide. These facilities are equipped with advanced technologies that allow for large-scale production while maintaining high-quality standards.

4. Skilled Workforce:


India has a large pool of skilled scientists, chemists, and technicians with expertise in pharmaceutical manufacturing. The country's scientific and technical workforce is well-versed in the latest manufacturing techniques and adheres to rigorous quality standards during the production of APIs like Citalopram Hydrobromide.

5. Global Reach:


Indian manufacturers have established a strong presence in international markets, exporting APIs to countries across the world. With established distribution channels and regulatory certifications, India-based API suppliers can efficiently cater to the growing global demand for Citalopram Hydrobromide.

6. Custom Manufacturing and Flexibility:


Indian API manufacturers are often able to provide customized solutions to meet the specific needs of their clients. This includes providing different batch sizes, packaging options, and other tailored requirements based on the customer's needs.

Top Citalopram Hydrobromide API Manufacturers in India


Several reputable manufacturers in India specialize in the production of Citalopram Hydrobromide API. These companies adhere to the highest standards of manufacturing and quality control to produce pharmaceutical-grade APIs for global distribution.

KekulePharma


KekulePharma is one of the leading manufacturers and suppliers of Citalopram Hydrobromide API in India. The company operates state-of-the-art manufacturing facilities that comply with international quality standards, including CGMP and USFDA certifications. KekulePharma is committed to producing high-quality APIs and has a strong reputation for its commitment to excellence in product quality. They offer Citalopram Hydrobromide API at competitive prices and cater to both domestic and international markets.

Aurobindo Pharma


Aurobindo Pharma is another major player in India's pharmaceutical manufacturing sector. They produce a wide range of APIs, including Citalopram Hydrobromide. The company has an extensive global reach, with products exported to more than 150 countries. Aurobindo Pharma adheres to strict regulatory standards and is known for its high-quality APIs and affordable pricing.

Hetero Drugs


Hetero Drugs is a well-known pharmaceutical company that produces Citalopram Hydrobromide and other APIs. With a strong presence in the global market, Hetero Drugs is a trusted supplier of high-quality APIs. The company operates GMP-certified facilities and offers Citalopram Hydrobromide API in large quantities to pharmaceutical manufacturers worldwide.

Citalopram Hydrobromide is an essential API used in the treatment of depression, anxiety, and other mental health conditions. With the increasing global demand for this API, India has emerged as a key supplier due to its cost-effective manufacturing, skilled workforce, and adherence to international regulatory standards. Indian manufacturers like KekulePharma, Aurobindo Pharma, and Hetero Drugs continue to produce high-quality Citalopram Hydrobromide, ensuring a steady supply to pharmaceutical companies worldwide.


Whether you're a pharmaceutical company looking for a reliable source of Citalopram Hydrobromide API or seeking to understand the manufacturing process, India remains a top destination for sourcing high-quality APIs at competitive prices.

Leave a Reply

Your email address will not be published. Required fields are marked *